Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.25 USD | +0.54% | +10.38% | +42.31% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+42.31% | 584M | |
-0.07% | 89.46B | |
+2.76% | 40.74B | |
-9.06% | 33.03B | |
+55.32% | 24.68B | |
-16.61% | 15.12B | |
-9.14% | 12.81B | |
-12.11% | 11.79B | |
-43.61% | 11.64B | |
+7.79% | 8.9B |
- Stock Market
- Equities
- CDMO Stock
- News Avid Bioservices, Inc.
- Transcript : Avid Bioservices, Inc. Presents at Morgan Stanley 19th Annual Global Healthcare Conference, Sep-09-2021 02